Search research articles
Contact Us
Filters
Showing results (211-220 of 298) with videos related to
Page
of 30
Sort By:
The Lancet. Neurology
|
February 24, 2017
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Valerie Voon, T Celeste Napier, Michael J Frank, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 6, 2013
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism
Julien Pierre Dupuis, Michael Feyder, Cristina Miguelez, et al.
Neurobiology of Disease
|
March 14, 2015
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly
Pedro Barroso-Chinea, Marie-Laure Thiolat, Simone Bido, et al.
Neurobiology of Disease
|
April 15, 2014
Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies
Pierre-Olivier Fernagut, Benjamin Dehay, Aline Maillard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 13, 2016
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease
Annalisa Pinna, Wai Kin D Ko, Giulia Costa, et al.
Journal of Medicinal Chemistry
|
June 9, 2021
Adenosine A<sub>2A</sub>R/A<sub>1</sub>R Antagonists Enabling Additional H<sub>3</sub>R Antagonism for the Treatment of Parkinson's Disease
Stefanie Hagenow, Anna Affini, Elsa Y Pioli, et al.
Bioconjugate Chemistry
|
November 15, 2018
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases
Geoffrey Prévot, Federico N Soria, Marie-Laure Thiolat, et al.
Neurobiology of Disease
|
April 16, 2017
In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains
Fabio Cavaliere, Loic Cerf, Benjamin Dehay, et al.
Communications Biology
|
November 25, 2025
Alzheimer's Tau seeds-induced pathology enhances hippocampal extracellular diffusion
Juan Estaún-Panzano, Anna Lovisotto, Claire Mazzocco, et al.
Aging Cell
|
March 23, 2022
Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function
Marie-Laure Arotcarena, Federico N Soria, Anthony Cunha, et al.
Page
of 30
Search research articles
Search
Showing results (211-220 of 298) with videos related to
Sort By:
Page
of 30
The Lancet. Neurology
|
February 24, 2017
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
Valerie Voon, T Celeste Napier, Michael J Frank, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 6, 2013
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism
Julien Pierre Dupuis, Michael Feyder, Cristina Miguelez, et al.
Neurobiology of Disease
|
March 14, 2015
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly
Pedro Barroso-Chinea, Marie-Laure Thiolat, Simone Bido, et al.
Neurobiology of Disease
|
April 15, 2014
Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies
Pierre-Olivier Fernagut, Benjamin Dehay, Aline Maillard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 13, 2016
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease
Annalisa Pinna, Wai Kin D Ko, Giulia Costa, et al.
Journal of Medicinal Chemistry
|
June 9, 2021
Adenosine A<sub>2A</sub>R/A<sub>1</sub>R Antagonists Enabling Additional H<sub>3</sub>R Antagonism for the Treatment of Parkinson's Disease
Stefanie Hagenow, Anna Affini, Elsa Y Pioli, et al.
Bioconjugate Chemistry
|
November 15, 2018
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases
Geoffrey Prévot, Federico N Soria, Marie-Laure Thiolat, et al.
Neurobiology of Disease
|
April 16, 2017
In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains
Fabio Cavaliere, Loic Cerf, Benjamin Dehay, et al.
Communications Biology
|
November 25, 2025
Alzheimer's Tau seeds-induced pathology enhances hippocampal extracellular diffusion
Juan Estaún-Panzano, Anna Lovisotto, Claire Mazzocco, et al.
Aging Cell
|
March 23, 2022
Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function
Marie-Laure Arotcarena, Federico N Soria, Anthony Cunha, et al.
Page
of 30